186 related articles for article (PubMed ID: 19115995)
1. PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway.
Cheng ZY; Guo XL; Yang XY; Niu ZY; Li SH; Wang SY; Chen H; Pan L
J Exp Clin Cancer Res; 2008 Dec; 27(1):87. PubMed ID: 19115995
[TBL] [Abstract][Full Text] [Related]
2. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
3. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
[TBL] [Abstract][Full Text] [Related]
4. [The role of PTEN-FAK signaling pathway in metastasis and invasive ability of leukemia cells].
Cheng ZY; Guo XL; Li SH; Wang SY; Yang XY; Xue F; Wen SP; Pan L
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):115-20. PubMed ID: 19563023
[TBL] [Abstract][Full Text] [Related]
5. [Effects of wild type PTEN gene on proliferation, apoptosis and the influence on apoptosis key factor Bcl-2 and Caspase family on K562 cells].
Cheng ZY; Liang WT; Niu ZY; Xue F; Yao L; Pan L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):679-83. PubMed ID: 19764572
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin pathway inhibition enhances the effects of 5-aza-dC on suppressing cell proliferation in human gastric cancer cell lines.
Sun D; Toan X; Zhang Y; Chen Y; Lu R; Wang X; Fang J
Sci China C Life Sci; 2008 Jul; 51(7):640-7. PubMed ID: 18622747
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of up-regulating PTEN gene on increasing the chemosensitivity in K562/ADM cells].
Zhang H; Yang LC; Cao LZ; Yang MH; Xie M; Zhu S; Zeng P; Yu Y
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):412-6. PubMed ID: 22781804
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
Kaper F; Dornhoefer N; Giaccia AJ
Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
[TBL] [Abstract][Full Text] [Related]
10. EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells.
Li T; Yang Y; Li X; Xu C; Meng L
Mol Cell Biochem; 2012 Feb; 361(1-2):19-29. PubMed ID: 21952748
[TBL] [Abstract][Full Text] [Related]
11. [PTEN and p27Kip1 have a cooperative role on inhibition proliferation, modulation of cell cycle and inducing apoptosis in prostate cancer PC-3 cell].
Qiu Z; Sun YH; Xu CL; Wang YT; Gu ZQ; Liu Y
Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):600-3. PubMed ID: 15265403
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.
Bae-Jump VL; Zhou C; Gehrig PA; Whang YE; Boggess JF
Gynecol Oncol; 2006 Mar; 100(3):487-94. PubMed ID: 16249016
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway.
Shi Y; Sharma A; Wu H; Lichtenstein A; Gera J
J Biol Chem; 2005 Mar; 280(12):10964-73. PubMed ID: 15634685
[TBL] [Abstract][Full Text] [Related]
14. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.
Steelman LS; Navolanic PM; Sokolosky ML; Taylor JR; Lehmann BD; Chappell WH; Abrams SL; Wong EW; Stadelman KM; Terrian DM; Leslie NR; Martelli AM; Stivala F; Libra M; Franklin RA; McCubrey JA
Oncogene; 2008 Jul; 27(29):4086-95. PubMed ID: 18332865
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
Li J; Xue L; Hao H; Han Y; Yang J; Luo J
Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902
[TBL] [Abstract][Full Text] [Related]
16. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.
Gera JF; Mellinghoff IK; Shi Y; Rettig MB; Tran C; Hsu JH; Sawyers CL; Lichtenstein AK
J Biol Chem; 2004 Jan; 279(4):2737-46. PubMed ID: 14576155
[TBL] [Abstract][Full Text] [Related]
17. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107.
Khor ES; Wong PF
Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052
[TBL] [Abstract][Full Text] [Related]
18. AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.
Vartanian R; Masri J; Martin J; Cloninger C; Holmes B; Artinian N; Funk A; Ruegg T; Gera J
Mol Cancer Res; 2011 Jan; 9(1):115-30. PubMed ID: 21135252
[TBL] [Abstract][Full Text] [Related]
19. mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.
Boudra R; Lagrafeuille R; Lours-Calet C; de Joussineau C; Loubeau-Legros G; Chaveroux C; Saru JP; Baron S; Morel L; Beaudoin C
Cell Cycle; 2016 May; 15(10):1352-62. PubMed ID: 27050906
[TBL] [Abstract][Full Text] [Related]
20. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
